The global intravenous solutions market is witnessing a rising demand from patients suffering from chronic diseases. Intravenous solutions play a major role in replacing fluid loss due to vomiting, diarrhea, excessive sweating, and decreased fluid intake caused by diseases. Intravenous fluid administration helps maintain adequate circulation of blood and prevent dehydration. Wide applications in therapeutic areas, such as chemotherapy, total parenteral nutrition (TPN), and enteral nutrition, also account for the growing consumption of intravenous solutions. The continuous rising prevalence of chronic diseases, like cancer, diabetes, gastrointestinal disorders, and cardiovascular diseases, is estimated to boost the demand for intravenous therapies and bolster market growth.

Global intravenous solutions market is estimated to be valued at USD 11.04 Bn in 2024 and is expected to exhibit a CAGR of 6.1% during the forecast period (2024-2031).

. Intravenous solutions are used in various therapies such as chemotherapy, total parental nutrition, and enteral nutrition for fluid replacement as well as delivery of medications. The wide applications of IV therapy bags and containers in the healthcare industry has augmented the growth of the market. Moreover, rising geriatric population and increasing prevalence of chronic diseases that require fluid replenishment has also propelled the demand for intravenous solutions.

Key Takeaways

Key players operating in the Intravenous Solutions market include Amcor plc, Bemis Company Inc. (acquired by Amcor), Sonoco Products Company, Sealed Air Corporation, and DS Smith Plc. Amcor plc and Bemis Company Inc. are the largest players in the IV bags market and hold a significant share.

The global Intravenous Solutions Market Trends  has witnessed rising demand owing to increasing prevalence of chronic and life-threatening diseases. Therapies like chemotherapy, total parenteral nutrition and enteral nutrition require IV fluids for medication administration and fluid replacement. Chronic diseases like cancer, cardiovascular diseases, gastrointestinal disorders and diabetes have risen worldwide thereby driving volume demand for IV solutions.

Geographically, North America dominates the Global Intravenous Solutions Market  Regional Analysis due to increasing healthcare expenditure and developed healthcare infrastructure. However, Asia Pacific region is expected to exhibit fastest growth during the forecast period owing to rising medical tourism, growing incidence of chronic diseases and improving access to healthcare in emerging countries. Key players are focusing on expansion in emerging markets to leverage high growth opportunities.

Market Drivers

A key factor driving the growth of the intravenous solutions market is the increasing prevalence of chronic diseases worldwide. Chronic conditions like cancer, cardiovascular diseases, gastrointestinal disorders and diabetes require fluid replacement and medication administration through IV which significantly contributes to the high and increasing demand for intravenous solutions. According to the World Health Organization (WHO), chronic diseases are estimated to account for 60% of all deaths globally. The growing geriatric population is also susceptible to chronic health conditions augmenting the need for IV therapies and solutions. Moreover, advancements in IV therapy and rising healthcare expenditure in developing nations are expected to propel the intravenous solutions market during the forecast period.

The current geopolitical uncertainties stemming from the ongoing Russia-Ukraine war and tensions between the US and China are impacting global supply chains and trade. This is affecting the growth of the intravenous solutions market. Both Russia and Ukraine are major exporters of raw materials like aluminum, plastics and other packaging materials that are crucial for manufacturing intravenous solution bags and bottles. The ongoing conflict has disrupted export of these materials from the Black Sea region, putting upward pressure on their prices in global markets. This is raising production costs for intravenous solution manufacturers. Many companies are facing difficulties in procuring raw materials at affordable rates. The market is also witnessing material shortages at times.
Some manufacturers are exploring alternative sourcing options from other regions like Middle East and Asia Pacific to deal with supply disruptions. However, switching to new vendors involves additional costs and logistical challenges. Companies will have to diversify their supplier base globally and maintain higher inventory levels of key materials to mitigate geopolitical and trade risks in the future. They also need to factor in uncertainties around fluctuations in raw material prices while setting business strategies and investment plans over the next 5-8 years.

The North American region presently accounts for the largest share of the overall intravenous solutions market in terms of value. This is because of high accessibility to quality healthcare services, growing prevalence of chronic diseases, rising medical expenses driven by an aging population and presence of leading market players in the US and Canada. However, Asia Pacific is emerging as the fastest growing regional market for intravenous solutions propelled by large patient pools, increasing healthcare investments, growing awareness about IV therapy and expansion of private healthcare facilities in China and India. Countries like China, Japan, India, Australia and South Korea are expected to offer lucrative opportunities for players over the next decade.

Get more insights on Intravenous Solutions Market